Tandem Diabetes Care Statistics
Share Statistics
Tandem Diabetes Care has 65.68M shares outstanding. The number of shares has increased by 0.39% in one year.
| Shares Outstanding | 65.68M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 1.36% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 65.20M |
| Failed to Deliver (FTD) Shares | 9.05K |
| FTD / Avg. Volume | 0.65% |
Short Selling Information
The latest short interest is 8.39M, so 12.78% of the outstanding shares have been sold short.
| Short Interest | 8.39M |
| Short % of Shares Out | 12.78% |
| Short % of Float | 12.88% |
| Short Ratio (days to cover) | 6.85 |
Valuation Ratios
The PE ratio is -8.62 and the forward PE ratio is -25.99.
| PE Ratio | -8.62 |
| Forward PE | -25.99 |
| PS Ratio | 2.57 |
| Forward PS | 2.2 |
| PB Ratio | 6.12 |
| P/FCF Ratio | -23.02 |
| PEG Ratio | n/a |
Enterprise Valuation
Tandem Diabetes Care Inc. has an Enterprise Value (EV) of 2.28B.
| EV / Earnings | -10.24 |
| EV / Sales | 3.05 |
| EV / EBITDA | -11.71 |
| EV / EBIT | -9.77 |
| EV / FCF | -27.32 |
Financial Position
The company has a current ratio of 3.83, with a Debt / Equity ratio of 0.96.
| Current Ratio | 3.83 |
| Quick Ratio | 3.02 |
| Debt / Equity | 0.96 |
| Total Debt / Capitalization | 49.06 |
| Cash Flow / Debt | -0.11 |
| Interest Coverage | -23.6 |
Financial Efficiency
Return on equity (ROE) is -0.71% and return on capital (ROIC) is -32.32%.
| Return on Equity (ROE) | -0.71% |
| Return on Assets (ROA) | -0.23% |
| Return on Capital (ROIC) | -32.32% |
| Revenue Per Employee | 311.55K |
| Profits Per Employee | -92.75K |
| Employee Count | 2.40K |
| Asset Turnover | 0.78 |
| Inventory Turnover | 2.41 |
Taxes
| Income Tax | 2.36M |
| Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by 14.15% in the last 52 weeks. The beta is 1.37, so Tandem Diabetes Care 's price volatility has been higher than the market average.
| Beta | 1.37 |
| 52-Week Price Change | 14.15% |
| 50-Day Moving Average | 33.18 |
| 200-Day Moving Average | 38.59 |
| Relative Strength Index (RSI) | 57.89 |
| Average Volume (20 Days) | 1.40M |
Income Statement
In the last 12 months, Tandem Diabetes Care had revenue of $747.72M and earned -$222.61M in profits. Earnings per share was $-3.43.
| Revenue | 747.72M |
| Gross Profit | 367.69M |
| Operating Income | -233.23M |
| Net Income | -222.61M |
| EBITDA | -194.66M |
| EBIT | -233.23M |
| Earnings Per Share (EPS) | -3.43 |
Balance Sheet
The company has $58.87M in cash and $415.67M in debt, giving a net cash position of -$356.80M.
| Cash & Cash Equivalents | 58.87M |
| Total Debt | 415.67M |
| Net Cash | -356.80M |
| Retained Earnings | -951.80M |
| Total Assets | 957.73M |
| Working Capital | 493.55M |
Cash Flow
In the last 12 months, operating cash flow was -$31.81M and capital expenditures -$51.60M, giving a free cash flow of -$83.41M.
| Operating Cash Flow | -31.81M |
| Capital Expenditures | -51.60M |
| Free Cash Flow | -83.41M |
| FCF Per Share | -1.29 |
Margins
Gross margin is 49.17%, with operating and profit margins of -31.19% and -29.77%.
| Gross Margin | 49.17% |
| Operating Margin | -31.19% |
| Pretax Margin | -29.46% |
| Profit Margin | -29.77% |
| EBITDA Margin | -26.03% |
| EBIT Margin | -31.19% |
| FCF Margin | -11.16% |
Dividends & Yields
TNDM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -10.5% |
| FCF Yield | -3.89% |
Analyst Forecast
The average price target for TNDM is $55, which is 68.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $55 |
| Price Target Difference | 68.3% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
Stock Splits
The last stock split was on Oct 10, 2017. It was a backward split with a ratio of 1:10.
| Last Split Date | Oct 10, 2017 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | 1.59 |
| Piotroski F-Score | 3 |